April 23, 2019
FDA considering additional regulatory actions to reduce duodenoscope risks
Editor's Note
The Food & Drug Administration on April 16 announced it is considering additional regulatory actions, including consulting with federal health experts for guidance, to reduce the risks of contamination and infections associated with duodenoscopes.
The FDA is also working with manufacturers of disposable duodenoscopes that would make reprocessing unnecessary and on new device designs that may decrease contamination risks.
Free Daily News
- ASC improves hospital efficiency, maintains outcomes despite higher-acuity joint replacement patients
- Hospital support staff cuts raise risk of infection, delays in care
- Study: Blocking stress-linked prolactin surge relieves postoperative pain in women
- Report ranks states by nursing opportunity
- Report: Hospitals double down on ASCs as outpatient shift accelerates
- Centralized waitlists slash joint replacement wait times in Canada, study shows
- Airborne bacteria pose hidden threat in cardiac ORs, study warns
- Simulation-based training boosts scrub nurses’ confidence in OR non-technical skills
- New AHRQ toolkit empowers OR teams to cut MRSA, SSI risk
- Study: Long working hours alter brain regions tied to emotion, cognition
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement